NCT00224510 - A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Bipolar DisorderBipolar Depression

Interventions

DRUG

lamotrigine

Trial Locations (31)

28035

GSK Investigational Site, Madrid

46009

GSK Investigational Site, Valencia

1815 JD

GSK Investigational Site, Alkmaar

7609 PP

GSK Investigational Site, Almelo

3818 EW

GSK Investigational Site, Amersfoort

1061 AE

GSK Investigational Site, Amsterdam

1075 GB

GSK Investigational Site, Amsterdam

2121 AD

GSK Investigational Site, Bennebroek

1261 AN

GSK Investigational Site, Blaricum

2625 AD

GSK Investigational Site, Delft

3317 NM

GSK Investigational Site, Dordrecht

5623 EJ

GSK Investigational Site, Eindhoven

7511JX

GSK Investigational Site, Enschede

4382 EE

GSK Investigational Site, Flushing

2803 RT

GSK Investigational Site, Gouda

9713 GZ

GSK Investigational Site, Groningen

1624 NP

GSK Investigational Site, Hoorn

2333 ZB

GSK Investigational Site, Leiden

6532 SZ

GSK Investigational Site, Nijmegen

8102 RR

GSK Investigational Site, Raalte

4525 LG

GSK Investigational Site, Retranchement

5248 NT

GSK Investigational Site, Rosmalen

2553 RJ

GSK Investigational Site, The Hague

5022 GC

GSK Investigational Site, Tilburg

3512 PG

GSK Investigational Site, Utrecht

6001 BE

GSK Investigational Site, Weert

8025 AB

GSK Investigational Site, Zwolle

01004

GSK Investigational Site, Alava

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona